Tandem Diabetes Care Announces Presentations Demonstrating Positive Real-World Improvements with Control-IQ Technology Across Diverse Populations – Business Wire

Tandem Diabetes Care presentations positive Real-World improvements from it’s insulin pump.

CONTEXT:  Tandem Diabetes Care announces a series of presentations at the 81st Scientific Sessions of the American Diabetes Association.  The presentations demonstrate positive Real-World improvements from ongoing use of their t:slim X2 insulin pump with Control-IQ technology across diverse populations.  Improvements were noted in both glycemic and patient reported outcomes. READ TIME:  3 mins 1. “Lead author, Dr. Jordan Pinsker, is currently the Medical Director at Tandem Diabetes Care. ”  2. “ADA PRESENTATION SUMMARIES Glycemic Outcomes by Ethnicity in Adults with Type 1 Diabetes Using Control-IQ Technology: Early Results from the CLIO Study Oral Presentation (217-OR) Session: Insulin Delivery Systems ”  3. “This presentation reported outcomes from the ongoing Control-IQ Observational (CLIO) study evaluating real-world use of the t:slim X2 insulin pump with Control-IQ technology in diverse groups of people with type 1 diabetes. ”  4. “After 180 days of starting Control-IQ technology, for prior pump users with type 1 diabetes, sensor TIR was 74% (median, IQR 65-81%) and time below <70mg/dL was 1. ”  Source URL: https://www.businesswire.com/news/home/20210627005025/en/Tandem-Diabetes-Care-Announces-Presentations-Demonstrating-Positive-Real-World-Improvements-with-Control-IQ-Technology-Across-Diverse-Populations